We studied the effects of intracerebroventricular (ICV) administration of angiotensin II (ANG II), bradykinin (BK), leucineenkephalin (Leu-ENK) and neurotensin (NT) on plasma renin activity (PRA), blood pressure and heart rate in acute (less than 4 weeks) and chronic (more than 12 weeks) two-kidney, one clip (2K-1C) hypertensive rats. These four peptides all produced pressor responses. The pressor responses caused by ICV injection of ANG II, BK, Leu-ENK and NT in hypertensive rats did not differ significantly from the response in normal rats. In both acute and chronic 2K-1C hypertensive rats, ANG II and BK significantly suppressed PRA, NT did not affect PRA, and Leu-ENK produced a significant increase in PRA followed by a significant decrease in PRA. As compared to normal rats, suppression of PRA by ANG II and NT was attenuated or abolished but BK and Leu-ENK produced significant reductions in PRA in 2K-1C hypertensive rats. The results indicate that the effects of these four centrally administered peptides on blood pressure, heart rate and PRA in acute and chronic 2K-1C hypertensive rats were not essentially different from those in normal rats.
and NT all produced pressor responses in normal rats and in 2K-1C hypertensive rats. The magnitude of the increase in blood pressure caused by these peptides did not differ significantly among normal rats , acute and chronic 2K-1C hypertensive rats. The maximal increases in MBP after ICV injection of the peptides are shown in Fig .2(a) . Heart rate was measured at the time when the maximal pressor response was observed. Heart rate did not significantly change in any of the 3 groups after ICV injection of either ANG II or Leu-ENK . ICV injection of BK significantly increased heart rate in all 3 groups. Heart rate significant increased after ICV injection of NT in acute 2K-1C hypertensive rats , but did not significantly change in normal rats or in chronic 2K-1C hypertensive rats. The changes in heart rate after ICV injection of the peptides are shown in Fig.2(b) .
DISCUSSI
ICV injections of ANG II, BK, Leu-ENK and NT showed pressor responses in 2K-1C hypertensive as reported previously.16) Spontaneously hypertensive rats exhibit a marked supersensitivity to the central pressor responses of angiotensin, bradykinin and enkephalins.6),23) Chronic twokidney, two clip hypertensive rats had a significantly increased pressor response after central administration of ANG II compared with normotensive rats.24) Our experiments showed no significant difference between normal rats and 2K-1C hypertensive rats in pressor responses after ICV injection of ANG II, BK, Leu-ENK or NT.
There are at least two efferent pathways by which the central. nervous system influences renin secretion. One is the sympathetic nervous system and the other involves vasopressin which exerts an inhibitory control over renin secretion. There are several reports indicating that central administration of ANG II, BK, Leu-ENK or NT causes sympathetic nerve activation.25)-28) On the other hand, it is suggested that central administration of these peptides produces vasopressin release. 25),29)-31) The effect of central peptidergic stimulation on renin secretion may depend on the extent of sympathetic nerve activation and vasopressin release. But the possibility that the other mechanisms may exist is not excluded.
There is no report on the change in PRA following ICV injections of ANG II, BK, Leu-ENK or NT in 2K-1C hypertensive rats. In this experiment, ANG II and BK significantly suppressed PRA, NT did not affect PRA and Leu-ENK produced a significant increase in PRA followed by a significant decrease in PRA. Suzuki et al10) reported that ICV injection of sara-lasin or captopril resulted in a significant decrease in blood pressure and PRA in 2K-1C hypertensive rats. These results suggested that the decrease in PRA due to the blockade of the brain renin-angiotensin system attenuated the sympathetic nerve activation. Our results suggest that the release of vasopressin caused by centrally administered ANG II probably has an advantage over the stimulation of the sympathetic nervous system with regard to renin secretion.
We have reported that ICV injections of ANG II, BK, Leu-ENK or NT in sodium-restricted rats whose PRA is significantly elevated cause changes in PRA similar to those observed in normal rats.32) In conscious 2K-1C hypertensive rats with elevated PRA, central administration of these peptides caused changes in PRA which showed some differences compared with normal rats. Since pressor responses after ICV injection of these peptides were similar in normal and 2K-1C hypertensive rats, these differences in PRA response might be due to peripheral mechanisms such as sensitivity of the kidney to sympathetic nerve activation and plasma vasopressin concentration. In 2K-1C hypertensive rats, compared to normal rats, suppression in PRA by ICV injections of ANG II or NT were attenuated or abolished. But BK and Leu-ENK produced significant reductions in PRA only in 2K-1C hypertensive rats. The mechanism by which the difference was caused is not clear in this experiment.
In conclusion, the results indicate that the effects of these four centrally administered peptides on blood pressure, heart rate and PRA in acute and chronic 2K-1C hypertensive rats were not essentially different from those in normal rats, though the effect of BK on PRA in 2K-1C hypertensive rats was different from that in normal rats.
